Abstract
Carbohydrates are often referred to as the third molecular chain of life, and they represent the most important post-genomics research targets. Recent reports of their biological functions in signal transduction and cellular recognition have made them promising pharmaceutical targets and disease markers. Like nucleic acids and proteins, the three-dimensional (3D) structures of carbohydrates are important for their molecular functions. Currently, the most abundant source of biological carbohydrate structures is the Protein Data Bank (PDB). As its name indicates, the PDB is a protein structure database. However, carbohydrate structures have often been determined in complexes with protein molecules, as enzyme substrates, lectin ligands, or post-translational modifications. As of Jul 2006, the PDB contained 6,421 carbohydrate-protein complex structures, and the number is increasing rapidly. In this review, the current status of the PDB as the carbohydrate structure database, and the features of several databases derived from the PDB will be summarized. We will also introduce an overview of the bioinformatics tools currently available for analyses of carbohydrate 3D structures.
Keywords: hidden Markov models, Structural genomics, N-glycans, getCARBO program, Glycoconjugate Data Bank
Current Chemical Biology
Title: Current Aspects of Carbohydrate Structural Bioinformatics
Volume: 1 Issue: 3
Author(s): Taku Nakahara, Shin-Ichiro Nishimura and Tsuyoshi Shirai
Affiliation:
Keywords: hidden Markov models, Structural genomics, N-glycans, getCARBO program, Glycoconjugate Data Bank
Abstract: Carbohydrates are often referred to as the third molecular chain of life, and they represent the most important post-genomics research targets. Recent reports of their biological functions in signal transduction and cellular recognition have made them promising pharmaceutical targets and disease markers. Like nucleic acids and proteins, the three-dimensional (3D) structures of carbohydrates are important for their molecular functions. Currently, the most abundant source of biological carbohydrate structures is the Protein Data Bank (PDB). As its name indicates, the PDB is a protein structure database. However, carbohydrate structures have often been determined in complexes with protein molecules, as enzyme substrates, lectin ligands, or post-translational modifications. As of Jul 2006, the PDB contained 6,421 carbohydrate-protein complex structures, and the number is increasing rapidly. In this review, the current status of the PDB as the carbohydrate structure database, and the features of several databases derived from the PDB will be summarized. We will also introduce an overview of the bioinformatics tools currently available for analyses of carbohydrate 3D structures.
Export Options
About this article
Cite this article as:
Nakahara Taku, Nishimura Shin-Ichiro and Shirai Tsuyoshi, Current Aspects of Carbohydrate Structural Bioinformatics, Current Chemical Biology 2007; 1 (3) . https://dx.doi.org/10.2174/2212796810701030265
DOI https://dx.doi.org/10.2174/2212796810701030265 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Response to Audiovisual Stimuli Presented Peripherally by Visually Cued Endogenous Temporal Attention: An Event-Related Potentials Study
Neuroscience and Biomedical Engineering (Discontinued) NMR Spectroscopy of Paramagnetic Heme Proteins
Current Inorganic Chemistry (Discontinued) Quantitative Electroencephalogram (EEG) in Insomnia: A New Window on Pathophysiological Mechanisms
Current Pharmaceutical Design The Mechanism of Dead-in-Bed Syndrome and Other Sudden Unexplained Nocturnal Deaths
Current Diabetes Reviews Upper Airway Resistance Syndrome
Current Respiratory Medicine Reviews Adolescence and Borderline Behavior - Between Personality Development and Personality Disorder
Adolescent Psychiatry The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders
CNS & Neurological Disorders - Drug Targets Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy Gabapentin-Mediated Effects on Voltage- and Ligand-Gated Currents
Current Neuropharmacology Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
CNS & Neurological Disorders - Drug Targets Beta-arrestin Biased Agonism/Antagonism at Cardiovascular Seven Transmembrane-spanning Receptors
Current Pharmaceutical Design Perinatal and Neonatal Outcomes of Lithium-Treated and Untreated Bipolar Women During Pregnancy: A Review of Present Literature
Current Psychopharmacology Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
Current Neuropharmacology Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?
Current Pharmaceutical Design Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Alcoholism and its Effects on the Central Nervous System
Current Neurovascular Research Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity
Current Topics in Medicinal Chemistry Transgenic Mouse Models of Parkinsons Disease and Huntingtons Disease
CNS & Neurological Disorders - Drug Targets Central Serotonin2C Receptor: From Physiology to Pathology
Current Topics in Medicinal Chemistry Computational Methods for De novo Protein Design and its Applications to the Human Immunodeficiency Virus 1, Purine Nucleoside Phosphorylase, Ubiquitin Specific Protease 7, and Histone Demethylases
Current Drug Targets